These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7090358)

  • 1. [Serum lipid studies of hyperlipoproteinemia patients during diet therapy with pectin preparations].
    Apostolov I; Goranov I; Balabanski L; Krŭsteva A; Popova D
    Vutr Boles; 1982; 21(1):51-4. PubMed ID: 7090358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New combined diet regimen in treating hyperlipoproteinemia].
    Naumova R; Goranov I; Balabanski L
    Vutr Boles; 1981; 20(4):34-7. PubMed ID: 6895434
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of pectin on some electrolytes and trace elements in patients with hyperlipoproteinemia.
    Grudeva-Popova J; Sirakova I
    Folia Med (Plovdiv); 1998; 40(1):41-5. PubMed ID: 9630767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the active body-mass ratio (fatty mass) in hyperlipoproteinemias as affected by a combined dietetic regimen].
    Naumova R; Khandzhiev S
    Vutr Boles; 1982; 21(4):80-3. PubMed ID: 7147923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of soluble dietary fibres in treatment of hyperlipoproteinemias.
    Grudeva-Popova J; Krachanova M; Djurdjev A; Krachanov C
    Folia Med (Plovdiv); 1997; 39(1):39-43. PubMed ID: 9141790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of lipid metabolic coefficient K2 in patients with hyperlipoproteinemia type IV before and after reduction of triglyceride level by adapted diet therapy].
    Drouin P; Lambert D; Mejean L; Pointel JP; Debry G
    Nutr Metab; 1979; 23(5):416-28. PubMed ID: 225702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical research on the hypolipidemic action of a probucol preparation].
    Naumova R; Kerekovska M; Goranov I; Balabanski L
    Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dietetic treatment of hyperlipoproteinemias].
    Louis J; Antoine JM; Pointel JP; Debry G; Drouin P
    Sem Hop; 1983 Sep; 59(32):2273-8. PubMed ID: 6314517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contrast-unloading week in the complex therapy of patients with metabolic-alimentary obesity and its effect on changes in body weight and lipid metabolism indices].
    Loĭko VI; Baketova NN; Lebedeva EA; Kolmakov VN; Skovorodnikova ES
    Vopr Pitan; 1979; (5):30-3. PubMed ID: 516598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate].
    Schiffl H; Weidmann P; Fragiacomo C; Noseda G; Bachmann C
    Schweiz Med Wochenschr; 1985 Jun; 115(26):907-11. PubMed ID: 3927481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia.
    Phillipson BE; Rothrock DW; Connor WE; Harris WS; Illingworth DR
    N Engl J Med; 1985 May; 312(19):1210-6. PubMed ID: 3990714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia].
    Pristautz H; Stradner F
    Wien Med Wochenschr; 1986 Sep; 136(17):443-8. PubMed ID: 2879389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of omega-3-fatty acids on lipoprotein metabolism. Different effects in various phenotypes].
    Singer P; Hüve J
    Fortschr Med; 1991 Aug; 109(24):476-9. PubMed ID: 1937329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of fish oils on plasma lipid risk factors and esterified fatty acids in primary hyperlipoproteinemia].
    Zák A; Zeman M; Tvrzická E
    Sb Lek; 1997; 98(3):213-24. PubMed ID: 9601814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of plasma and biliary lipids in hyperlipoproteinaemia.
    Leijd B
    Acta Med Scand Suppl; 1979; 635():1-32. PubMed ID: 295570
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of lovastatin on serum lipids in patients with primary hyperlipidemia phenotype IIa and IIb. I. Efficacy of lovastatin in the treatment of hyperlipoproteinemia].
    Idzior-Waluś B
    Przegl Lek; 1992; 49(9):287-91. PubMed ID: 1302351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of hyperlipoproteinemia induced by the administration of an atherogenic lipoprotein fraction on various indices of lipid metabolism in rabbits].
    Bel'chenko DI; Khanina NIa; Kalinkin MN
    Vopr Med Khim; 1987; 33(3):42-5. PubMed ID: 3630013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of fenofibrate in various types of hyperlipoproteinemias].
    Sucić M
    Lijec Vjesn; 1989 Mar; 111(3):93-7. PubMed ID: 2747411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations.
    Kaffarnik H; Schneider J; Schubotz R; Zöfel P; Hausmann L; Goebel KM
    Artery; 1980; 8(6):537-46. PubMed ID: 6114725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.